Inside Indiana Business (press release) Low blood sugar (hypoglycemia): if you take JARDIANCE with another medicine that can cause low blood sugar, such as sulfonylurea...
JAMA: The Journal of the American Medical Association In Reply We agree with Drs Tasci and Safer that the risk of metformin and insulin compared with metformin plus sulfonylurea as a second-line diabetes treatment after failure of metformin monotherapy may differ in certain populations. They point to ... and more »
Medical Research News and Interviews on MedicalResearch.com (blog) Dr. Hodson: Type 2 diabetes represents a huge socioeconomic challenge. As well as causing significant morbidity due to chronically elevated glucose levels, this disease is also a drain on healthcare budgets (~$20billion in the UK per year). While ...
Tech Times "Compared with sulfonylurea monotherapy, metformin monotherapy was associated with a 55 percent increased risk of low TSH levels in patients with treated hy...
American Live Wire To help make better drugs, scientists belonging to the Imperial College London and the Ludwig Maximilian University situated in Munich adapted a previous type of drug called sulfonylurea so that it changes its shape on exposure to blue coloured light.
Laboratory Talk ICL researcher David Hodson. To help develop better treatments for diabetes sufferers, researchers at ICL and LMU Munich have adapted an existing type of drug called a sulfonylurea so that it changes shape when exposed to blue light. Richard Elliott ...
Medscape The investigators initially looked at a total 74,300 patients who were at least 40 years of age and had begun receiving either metformin or sulfonylurea monotherapy between 1988 and 2012. Of those, 5689 had treated hypothyroidism and 59,937 were ... and more »
TheHealthSite To help create better drugs, researchers at the Imperial College London and the Ludwig Maximilian University in Munich adapted an existing type of drug called a sulfonylurea so that it changes shape when exposed to blue light. They demonstrated that ...
Medical Research News and Interviews on MedicalResearch.com (blog) Dr. Hodson: Type 2 diabetes represents a huge socioeconomic challenge. As well as causing significant morbidity due to chronically elevated glucose levels, this disease is also a drain on healthcare budgets (~$20billion in the UK per year). While ...
Monthly Prescribing Reference Researchers at Imperial College London and LMU Munich have adapted a sulfonylurea that would remain inactive under normal conditions but would change shape and become activated when exposed to a transdermal blue LED. Dubbed JB153, this ...
